Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
2.
Neuroscience ; 253: 341-9, 2013 Dec 03.
Article in English | MEDLINE | ID: mdl-24036374

ABSTRACT

Indirect evidence suggests the increased production of reactive oxygen species (ROS) in migraine pathophysiology. In the current study we measured lipid peroxidation product in the rat cortex, trigeminal ganglia and meninges after the induction of cortical spreading depression (CSD), a phenomenon known to be associated with migraine aura, and tested nociceptive firing triggered by ROS in trigeminal nerves ex vivo. Application of KCl to dura mater in anesthetized rats induced several waves of CSD recorded by an extracellular electrode in the cortex. Following CSD, samples of cortex (affected regions were identified with blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI)), meninges from left and right hemispheres and trigeminal ganglia were taken for biochemical analysis. We found that CSD increased the level of the lipid peroxidation product malondialdehyde (MDA) in the ipsilateral cerebral cortex and meninges, but also in both ipsi- and contralateral trigeminal ganglia. In order to test the pro-nociceptive action of ROS, we applied the mild oxidant hydrogen peroxide to isolated rat hemiskull preparations including preserved trigeminal innervations. Application of hydrogen peroxide to meninges transiently enhanced electrical spiking activity of trigeminal nerves showing a pro-nociceptive action of ROS. In the presence of hydrogen peroxide trigeminal nerves still responded to capsaicin by burst of spiking activity indicating integrity of neuronal structures. The action of hydrogen peroxide was mediated by TRPA1 receptors as it was abolished by the specific TRPA1 antagonist TCS-5861528. Using dorsal root ganglion sensory neurons as test system we found that hydrogen peroxide promoted the release of the migraine mediator calcitonin gene-related peptide (CGRP), which we previously identified as a trigger of delayed sensitization of trigeminal neurons. Our data suggest that, after CSD, oxidative stress spreads downstream within the trigeminal nociceptive system and could be involved in the coupling of CSD with the activation of trigeminovascular system in migraine pathology.


Subject(s)
Cerebral Cortex/physiology , Cortical Spreading Depression/physiology , Meninges/metabolism , Oxidative Stress/physiology , Trigeminal Ganglion/metabolism , Analysis of Variance , Animals , Calcitonin Gene-Related Peptide/metabolism , Cerebral Cortex/blood supply , Cortical Spreading Depression/drug effects , Electric Stimulation , Hydrogen Peroxide/metabolism , Image Processing, Computer-Assisted , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Magnetic Resonance Imaging , Oxygen/blood , Potassium Chloride/pharmacology , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
3.
Cell Mol Life Sci ; 64(13): 1597-608, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17458500

ABSTRACT

Vesicle fusion is a ubiquitous biological process involved in membrane trafficking and a variety of specialised events such as exocytosis and neurite outgrowth. The energy to drive biological membrane fusion is provided by fusion proteins called SNAREs. Indeed, SNARE proteins play critical roles in neuronal development as well as neurotransmitter and hormone release. SNARE proteins form a very tight alpha-helical bundle that can pull two membranes together, thereby initiating fusion. Whereas a great deal of attention has been paid to partner proteins that can affect SNARE function, recent genetic and biochemical evidence suggests that local lipid environment may be as important in SNARE regulation. Direct lipid modification of SNARE fusion proteins and their regulation by fatty acids following phospholipase action will be discussed here in detail. Our analysis highlights the fact that lipids are not a passive platform in vesicle fusion but intimately regulate SNARE function.


Subject(s)
Fatty Acids/metabolism , Membrane Fusion , SNARE Proteins/metabolism , Amino Acid Sequence , Animals , Fatty Acids, Unsaturated/metabolism , Humans , Molecular Sequence Data , Palmitic Acid/chemistry , Palmitic Acid/metabolism , Phospholipases/metabolism , SNARE Proteins/chemistry
4.
J Neurochem ; 98(6): 1789-97, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16945102

ABSTRACT

Reactive oxygen species (ROS) participate in various physiological and pathological processes in the nervous system, but the specific pathways that mediate ROS signalling remain largely unknown. Using electrophysiological techniques and biochemical evaluation of isolated fusion proteins, we explored the sensitivity to standard oxidative stress of the entire synapse, the pre-synaptic machinery and essential fusion proteins underlying transmitter exocytosis. Oxidative stress induced by H(2)O(2) plus Fe(2+) inhibited both evoked and spontaneous quantal release from frog or mouse motor nerve endings, while it left post-synaptic sensitivity unchanged. The depressant effect of H(2)O(2) on acetylcholine release was pertussis toxin-insensitive, ruling out G-protein cascades. Experiments with ionomycin, a Ca(2+) ionophore, revealed that ROS directly impaired the function of releasing machinery. In line with this, SNAP25, one of three essential fusion proteins, showed a selectively high sensitivity to the oxidative signals. Several ROS scavengers enhanced evoked synaptic transmission, consistent with tonic inhibition by endogenous ROS. Our data suggest that ROS-induced impairment of releasing machinery is mediated by SNAP25, which appears to be a pre-synaptic ROS sensor. This mechanism of ROS signalling could have widespread implications in the nervous system and might contribute to the pathogenesis of neurodegenerative diseases.


Subject(s)
Muscle, Skeletal/innervation , Neurotransmitter Agents/antagonists & inhibitors , Presynaptic Terminals/metabolism , Reactive Oxygen Species/metabolism , Synaptosomal-Associated Protein 25/physiology , Animals , Antioxidants/pharmacology , Diaphragm/drug effects , Diaphragm/metabolism , Ferrous Compounds/pharmacology , Free Radical Scavengers/pharmacology , Hydrogen Peroxide/pharmacology , Hydroxyl Radical/metabolism , In Vitro Techniques , Ionomycin/pharmacology , Ionophores/pharmacology , Mice , Motor Endplate/drug effects , Motor Endplate/physiology , Oxidants/pharmacology , Oxidation-Reduction , Patch-Clamp Techniques , Synaptic Transmission/drug effects
5.
Nat Med ; 7(11): 1241-4, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11689890

ABSTRACT

The C2 domain of synaptotagmin I, which binds to anionic phospholipids in cell membranes, was shown to bind to the plasma membrane of apoptotic cells by both flow cytometry and confocal microscopy. Conjugation of the protein to superparamagnetic iron oxide nanoparticles allowed detection of this binding using magnetic resonance imaging. Detection of apoptotic cells, using this novel contrast agent, was demonstrated both in vitro, with isolated apoptotic tumor cells, and in vivo, in a tumor treated with chemotherapeutic drugs.


Subject(s)
Apoptosis , Calcium-Binding Proteins , Magnetic Resonance Imaging/methods , Animals , Antineoplastic Agents, Phytogenic/therapeutic use , Cell Membrane/metabolism , Contrast Media , Etoposide/therapeutic use , Ferric Compounds , Flow Cytometry , In Vitro Techniques , Magnetics , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/pathology , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Protein Binding , Protein Structure, Tertiary , Rats , Synaptotagmin I , Synaptotagmins
6.
Biochimie ; 82(5): 453-68, 2000 May.
Article in English | MEDLINE | ID: mdl-10865132

ABSTRACT

A novel procedure of alpha-latrotoxin (alpha LTX) purification has been developed. Pure alpha LTX has been demonstrated to exist as a very stable homodimer. Such dimers further assemble into tetramers, and Ca(2+), Mg(2+) or higher toxin concentrations facilitate this process. However, when the venom is treated with EDTA, purified alpha LTX loses the ability to tetramerise spontaneously; the addition of Mg(2+) or Ca(2+) restores this ability. This suggests that alphaLTX has some intrinsically bound divalent cation(s) that normally support its tetramerisation. Single-particle cryoelectron microscopy and statistical image analysis have shown that: 1) the toxin has a non-compact, branching structure; 2) the alpha LTX dimers are asymmetric; and 3) the tetramers are symmetric and have a 25 A-diameter channel in the centre. Both alpha LTX oligomers bind to the same receptors in synaptosomes and rat brain sections. To study the effects of the dimers and tetramers on norepinephrine release from rat cerebrocortical synaptosomes, we used the EDTA-treated and untreated toxin preparations. The number of tetramers present in a preparation correlates with alpha LTX pore formation, suggesting that the tetramers are the pore-forming species of alpha LTX. The toxin actions mediated by the pore include: 1) Ca(2+) entry from the extracellular milieu; and 2) passive efflux of neurotransmitters via the pore that occurs independently of Ca(2+). The Ca(2+)-dependent alpha LTX-stimulated secretion conforms to all criteria of vesicular exocytosis but also depends upon intact intracellular Ca(2+) stores and functional phospholipase C (PLC). The Ca(2+)-dependent effect of the toxin is stronger when dimeric alpha LTX is used, indicating that higher receptor occupancy leads to its stronger activation, which contributes to stimulation of neuroexocytosis. In contrast, the Ca(2+)-independent release measured biochemically represents leakage of neurotransmitters through the toxin pore. These results are discussed in relation to the previously published observations.


Subject(s)
Exocytosis/drug effects , Spider Venoms/chemistry , Spider Venoms/pharmacology , Synaptosomes/metabolism , Animals , Brain/metabolism , Calcium/metabolism , Cations, Divalent/metabolism , Cell Membrane/metabolism , Cryoelectron Microscopy , Dimerization , Electrophoresis, Polyacrylamide Gel , Exocytosis/physiology , Norepinephrine/metabolism , Protein Structure, Quaternary , Rats , Receptors, Peptide/metabolism , Spider Venoms/isolation & purification , Spider Venoms/metabolism , Synaptosomes/drug effects
7.
Philos Trans R Soc Lond B Biol Sci ; 354(1381): 379-86, 1999 Feb 28.
Article in English | MEDLINE | ID: mdl-10212487

ABSTRACT

alpha-latrotoxin (LTX) stimulates massive release of neurotransmitters by binding to a heptahelical transmembrane protein, latrophilin. Our experiments demonstrate that latrophilin is a G-protein-coupled receptor that specifically associates with heterotrimeric G proteins. The latrophilin-G protein complex is very stable in the presence of GDP but dissociates when incubated with GTP, suggesting a functional interaction. As revealed by immunostaining, latrophilin interacts with G alpha q/11 and G alpha o but not with G alpha s, G alpha i or G alpha z, indicating that this receptor may couple to several G proteins but it is not promiscuous. The mechanisms underlying LTX-evoked norepinephrine secretion from rat brain nerve terminals were also studied. In the presence of extracellular Ca2+, LTX triggers vesicular exocytosis because botulinum neurotoxins E, Cl or tetanus toxin inhibit the Ca(2+)-dependent component of the toxin-evoked release. Based on (i) the known involvement of G alpha q in the regulation of inositol-1,4,5-triphosphate generation and (ii) the requirement for Ca2+ in LTX action, we tested the effect of inhibitors of Ca2+ mobilization on the toxin-evoked norepinephrine release. It was found that aminosteroid U73122, which inhibits the coupling of G proteins to phospholipase C, blocks the Ca(2+)-dependent toxin's action. Thapsigargin, which depletes intracellular Ca2+ stores, also potently decreases the effect of LTX in the presence of extracellular Ca2+. On the other hand, clostridial neurotoxins or drugs interfering with Ca2+ metabolism do not inhibit the Ca2(+)-independent component of LTX-stimulated release. In the absence of Ca2+, the toxin induces in the presynaptic membrane non-selective pores permeable to small fluorescent dyes; these pores may allow efflux of neurotransmitters from the cytoplasm. Our results suggest that LTX stimulates norepinephrine exocytosis only in the presence of external Ca2+ provided intracellular Ca2+ stores are unperturbed and that latrophilin, G proteins and phospholipase C may mediate the mobilization of stored Ca2+, which then triggers secretion.


Subject(s)
Exocytosis/drug effects , Exocytosis/physiology , Norepinephrine/metabolism , Spider Venoms/pharmacology , Animals , Calcium/pharmacology , Calcium/physiology , GTP-Binding Proteins/physiology , In Vitro Techniques , Rats , Receptors, Peptide/physiology , Synaptosomes/drug effects , Synaptosomes/physiology , Type C Phospholipases/physiology
8.
J Biol Chem ; 273(30): 19093-6, 1998 Jul 24.
Article in English | MEDLINE | ID: mdl-9668093

ABSTRACT

C2 domains have been identified in a wide range of intracellular proteins, including lipid modifying enzymes, protein kinases, GTPases, and proteins involved in membrane trafficking. Many C2 domains bind membranes in a calcium-dependent manner. The first C2 domain from synaptotagmin I (SytIC2A) and the C2 domain from cytosolic phospholipase A2 (cPLA2C2) are among the best characterized C2 domains in terms of their structures and calcium binding. Here we demonstrate that the protein-lipid interaction is dramatically different for these two domains. Photolabeling with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine ([125I]TID) in the presence of phospholipid vesicles indicates that cPLA2C2 penetrates into the hydrophobic region of the membrane. Hydrophobic surfaces on cPLA2C2 are exposed even in the absence of calcium, but only in its presence does the domain penetrate into the nonpolar core of the membrane. The interaction of SytIC2A with phospholipid membranes is primarily electrostatic with binding being abolished in 500 mM NaCl. Because soluble phospholipid head group analogues do not compete with binding of either SytIC2A or cPLA2C2 to vesicles, it is likely that membrane binding by these domains involves multiple interactions.


Subject(s)
Calcium-Binding Proteins/metabolism , Calcium/metabolism , Cytosol/enzymology , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Phospholipases A/metabolism , Animals , Binding Sites , Brain/metabolism , Cell Membrane/metabolism , Cells, Cultured , Osmolar Concentration , Phospholipases A2 , Static Electricity , Synaptotagmin I , Synaptotagmins
9.
EMBO J ; 17(14): 3909-20, 1998 Jul 15.
Article in English | MEDLINE | ID: mdl-9670008

ABSTRACT

alpha-Latrotoxin (LTX) stimulates massive neurotransmitter release by two mechanisms: Ca2+-dependent and -independent. Our studies on norepinephrine secretion from nerve terminals now reveal the different molecular basis of these two actions. The Ca2+-dependent LTX-evoked vesicle exocytosis (abolished by botulinum neurotoxins) is 10-fold more sensitive to external Ca2+ than secretion triggered by depolarization or A23187; it does not, however, depend on the cation entry into terminals but requires intracellular Ca2+ and is blocked by drugs depleting Ca2+ stores and by inhibitors of phospholipase C (PLC). These data, together with binding studies, prove that latrophilin, which is linked to G proteins and inositol polyphosphate production, is the major functional LTX receptor. The Ca2+-independent LTX-stimulated release is not inhibited by botulinum neurotoxins or drugs interfering with Ca2+ metabolism and occurs via pores in the presynaptic membrane, large enough to allow efflux of neurotransmitters and other small molecules from the cytoplasm. Our results unite previously contradictory data about the toxin's effects and suggest that LTX-stimulated exocytosis depends upon the co-operative action of external and intracellular Ca2+ involving G proteins and PLC, whereas the Ca2+-independent release is largely non-vesicular.


Subject(s)
Calcium/physiology , Exocytosis/drug effects , Norepinephrine/metabolism , Receptors, Peptide/metabolism , Spider Venoms/pharmacology , Animals , Botulinum Toxins/pharmacology , COS Cells , Calcimycin/pharmacology , Estrenes/pharmacology , Glycoproteins , Ionophores/pharmacology , Male , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neuromuscular Junction/metabolism , Neuropeptides , Phosphodiesterase Inhibitors/pharmacology , Pyrrolidinones/pharmacology , Rana esculenta , Rats , Reserpine/pharmacology , Spider Venoms/metabolism , Synaptosomes , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/physiology
10.
J Biol Chem ; 272(34): 21504-8, 1997 Aug 22.
Article in English | MEDLINE | ID: mdl-9261169

ABSTRACT

alpha-Latrotoxin (LTX) stimulates massive exocytosis of synaptic vesicles and may help to elucidate the mechanism of regulation of neurosecretion. We have recently isolated latrophilin, the synaptic Ca2+-independent LTX receptor. Now we demonstrate that latrophilin is a novel member of the secretin family of G protein-coupled receptors that are involved in secretion. Northern blot analysis shows that latrophilin message is present only in neuronal tissue. Upon expression in COS cells, the cloned protein is indistinguishable from brain latrophilin and binds LTX with high affinity. Latrophilin physically interacts with a Galphao subunit of heterotrimeric G proteins, because the two proteins co-purify in a two-step affinity chromatography. Interestingly, extracellular domain of latrophilin is homologous to olfactomedin, a soluble neuronal protein thought to participate in odorant binding. Our findings suggest that latrophilin may bind unidentified endogenous ligands and transduce signals into nerve terminals, thus implicating G proteins in the control of synaptic vesicle exocytosis.


Subject(s)
Receptors, Peptide/metabolism , Spider Venoms/metabolism , Amino Acid Sequence , Animals , Exocytosis , GTP-Binding Proteins/physiology , Membrane Glycoproteins/chemistry , Molecular Sequence Data , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Rats , Receptors, Peptide/chemistry , Sequence Alignment , Sequence Homology, Amino Acid , Signal Transduction , Synaptic Vesicles/metabolism
11.
J Biol Chem ; 271(38): 23239-45, 1996 Sep 20.
Article in English | MEDLINE | ID: mdl-8798521

ABSTRACT

alpha-Latrotoxin, a black widow spider neurotoxin, can bind to high affinity receptors on the presynaptic plasma membrane and stimulate massive neurotransmitter release in the absence of Ca2+. Neurexins, previously isolated as alpha-latrotoxin receptors, require Ca2+ for their interaction with the toxin and, thus, may not participate in the Ca2+-independent alpha-latrotoxin activity. We now report the isolation of a novel protein that binds alpha-latrotoxin with high affinity in the presence of various divalent cations (Ca2+, Mg2+, Ba2+, and Sr2+) as well as in EDTA. This protein, termed here latrophilin, has been purified from detergent-solubilized bovine brain membranes by affinity chromatography on immobilized alpha-latrotoxin and concentrated on a wheat germ agglutinin affinity column. The single polypeptide chain of latrophilin is N-glycosylated and has an apparent molecular weight of 120,000. Sucrose gradient centrifugations demonstrated that latrophilin and alpha-latrotoxin form a stable equimolar complex. In the presence of the toxin, anti-alpha-latrotoxin antibodies precipitated iodinated latrophilin, whose binding to immobilized toxin was characterized by a dissociation constant of 0.5-0.7 nM. This presumably membrane-bound protein is localized to and differentially distributed among neuronal tissues, with about four times more latrophilin expressed in the cerebral cortex than in the cerebellum; subcellular fractionation showed that the protein is highly enriched in synaptosomal plasma membranes. Our data suggest that latrophilin may represent the Ca2+-independent receptor and/or molecular target for alpha-latrotoxin.


Subject(s)
Calcium/pharmacology , Nerve Tissue Proteins/metabolism , Receptors, Peptide/metabolism , Spider Venoms/metabolism , Amino Acid Sequence , Animals , Cattle , Membrane Glycoproteins/drug effects , Membrane Glycoproteins/isolation & purification , Membrane Glycoproteins/metabolism , Molecular Sequence Data , Nerve Tissue Proteins/drug effects , Nerve Tissue Proteins/isolation & purification , Protein Binding , Rats , Receptors, Peptide/drug effects , Receptors, Peptide/isolation & purification , Sequence Analysis , Species Specificity , Synaptosomes/chemistry , Tissue Distribution
12.
Science ; 273(5272): 248-51, 1996 Jul 12.
Article in English | MEDLINE | ID: mdl-8662510

ABSTRACT

C2 domains are found in many proteins involved in membrane traffic or signal transduction. Although C2 domains are thought to bind calcium ions, the structural basis for calcium binding is unclear. Analysis of calcium binding to C2 domains of synaptotagmin I and protein kinase C-beta by nuclear magnetic resonance spectroscopy revealed a bipartite calcium-binding motif that involves the coordination of two calcium ions by five aspartate residues located on two separate loops. Sequence comparisons indicated that this may be a widely used calcium-binding motif, designated here as the C2 motif.


Subject(s)
Calcium-Binding Proteins , Calcium/metabolism , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Protein Kinase C/metabolism , Aspartic Acid/chemistry , Base Sequence , Crystallography, X-Ray , Hydrogen-Ion Concentration , Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Sequence Data , Phospholipids/metabolism , Protein Conformation , Protein Folding , Protein Kinase C/chemistry , Protein Structure, Secondary , Protein Structure, Tertiary , Synaptotagmin I , Synaptotagmins , Temperature
13.
J Biol Chem ; 270(42): 24898-902, 1995 Oct 20.
Article in English | MEDLINE | ID: mdl-7559614

ABSTRACT

Ca(2+)-dependent neurotransmitter release consists of at least two components: a major fast component that is insensitive to Sr2+ and a minor slow component that is potentiated by Sr2+ (Goda, Y., and Stevens, C. F. (1994) Proc. Natl. Acad. U. S. A. 91, 12942-12946). These results suggest that at least two Ca2+ sensors act in synaptic vesicle fusion with distinct Ca2+ and Sr2+ binding properties. We have now investigated the relative Ca2+ and Sr2+ binding activities of synaptotagmins to evaluate their potential roles as Ca2+ sensors for the fast and slow components. Our results demonstrate that the first C2 domains of synaptotagmins I, II, III, V, and VII have very similar Ca2+ requirements for phospholipid binding (range of EC50 = 2.6 microM to 5.0 microM), but distinct Sr2+ requirements (EC50 range = 23 microM to 133 microM); synaptotagmins I and II had the lowest Sr2+ affinity, and synaptotagmin III the highest Sr2+ affinity. Purified synaptotagmin I from bovine brain exhibited similar properties as its recombinant first C2 domain, suggesting that the first C2 domain fully accounts for its Ca(2+)-dependent phospholipid binding properties. Sr2+ was unable to trigger syntaxin binding by synaptotagmin I at all concentrations tested, whereas it was effective for synaptotagmin III. These results suggest that different C2 domains have distinct Sr2+ binding properties. They support the hypothesis that synaptotagmins localized on the same vesicle perform distinct functions, with synaptotagmins I and II serving as candidate Ca2+ sensors for the fast component in release and synaptotagmin III for the slow component.


Subject(s)
Calcium-Binding Proteins , Calcium/metabolism , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Neurotransmitter Agents/metabolism , Strontium/metabolism , Animals , Cattle , Membrane Proteins/metabolism , Phospholipids/metabolism , Qa-SNARE Proteins , Synaptotagmin I , Synaptotagmins
14.
J Biol Chem ; 270(41): 23903-5, 1995 Oct 13.
Article in English | MEDLINE | ID: mdl-7592578

ABSTRACT

alpha-Latrotoxin is a potent neurotoxin from black widow spider venom that stimulates neurotransmitter release. alpha-Latrotoxin is thought to act by binding to a high affinity receptor on presynaptic nerve terminals. In previous studies, high affinity alpha-latrotoxin binding proteins were isolated and demonstrated to contain neurexin I alpha as a major component. Neurexin I alpha is a cell surface protein that exists in multiple differentially spliced isoforms and belongs to a large family of neuron-specific proteins. Using a series of neurexin I-IgG fusion proteins, we now show that recombinant neurexin I alpha binds alpha-latrotoxin directly with high affinity (Kd approximately 4 nM). Binding of alpha-latrotoxin to recombinant neurexin I alpha is dependent on Ca2+ (EC50 approximately 30 microM). Our data suggest that neurexin I alpha is a Ca(2+)-dependent high affinity receptor for alpha-latrotoxin.


Subject(s)
Nerve Tissue Proteins/metabolism , Spider Venoms/metabolism , Alternative Splicing , Animals , Calcium/pharmacology , Cattle , Cell Line , Chlorocebus aethiops , Glycoproteins , Humans , Immunoglobulin G/biosynthesis , Kinetics , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/chemistry , Neuropeptides , Neurotoxins/chemistry , Neurotoxins/metabolism , Protein Binding , Rats , Recombinant Fusion Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Spider Venoms/chemistry , Transfection
15.
Cell ; 80(6): 929-38, 1995 Mar 24.
Article in English | MEDLINE | ID: mdl-7697723

ABSTRACT

C2 domains are regulatory sequence motifs that occur widely in nature. Synaptotagmin I, a synaptic vesicle protein involved in the Ca2+ regulation of exocytosis, contains two C2 domains, the first of which acts as a Ca2+ sensor. We now describe the three-dimensional structure of this C2 domain at 1.9 A resolution in both the Ca(2+)-bound and Ca(2+)-free forms. The C2 polypeptide forms an eight-stranded beta sandwich constructed around a conserved four-stranded motif designated as a C2 key. Ca2+ binds in a cup-shaped depression between two polypeptide loops located at the N- and C-termini of the C2-key motif.


Subject(s)
Calcium-Binding Proteins , Calcium/metabolism , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Phospholipids/metabolism , Protein Folding , Protein Structure, Secondary , Amino Acid Sequence , Base Sequence , Binding Sites , Conserved Sequence , Exocytosis , Liposomes , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Oligodeoxyribonucleotides , Phosphatidylcholines/metabolism , Phosphatidylserines/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Synaptic Vesicles/metabolism , Synaptotagmin I , Synaptotagmins
16.
J Biol Chem ; 269(46): 28547-50, 1994 Nov 18.
Article in English | MEDLINE | ID: mdl-7961798

ABSTRACT

Synaptotagmin I is a Ca2+/phospholipid binding protein of synaptic vesicles with a proposed function as a Ca2+ sensor in synaptic vesicle exocytosis. Using controlled partial proteolysis as an assay, we now show that synaptotagmin I undergoes a conformational change as a function of Ca2+ binding. As observed for phospholipid binding, Ba2+ and Sr2+ but not Mg2+, substitute for Ca2+ in effecting this conformational change. The first C2 domain from synaptotagmin I that represents the Ca(2+)-dependent phospholipid binding domain of synaptotagmin also undergoes a Ca(2+)-dependent change in controlled partial proteolysis. In contrast, no effect of Ca2+ was observed with mutant C2 domains containing point mutations that abolish Ca2+ binding. The Ca2+ concentration dependence of the effect of Ca2+ on proteolysis mirrors the Ca2+ dependence of phospholipid binding. The conformational shift in synaptotagmin I caused by Ca2+/phospholipid binding could be the basis for its Ca(2+)-regulated function in triggering neurotransmitter release.


Subject(s)
Calcium-Binding Proteins , Calcium/metabolism , Membrane Glycoproteins/chemistry , Nerve Tissue Proteins/chemistry , Animals , Exocytosis , Hydrolysis , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Protein Conformation , Rats , Synaptic Vesicles/metabolism , Synaptotagmin I , Synaptotagmins
17.
Cell ; 78(5): 751-60, 1994 Sep 09.
Article in English | MEDLINE | ID: mdl-8087843

ABSTRACT

In nerve terminals, Ca(2+)-stimulated synaptic vesicle exocytosis is rapidly followed by endocytosis. Synaptic vesicle endocytosis requires clathrin-coated pits similar to receptor-mediated endocytosis in fibroblasts. Binding of clathrin AP-2 (adaptor complex) to an unidentified high affinity membrane receptor appears to be necessary for coated pit assembly in fibroblasts. We now show that synaptic vesicles have a high affinity AP-2 site (KD, approximately 1 x 10(-10) M) similar to the one observed in fibroblasts. Using a combination of competition and direct binding assays, we demonstrate that synaptotagmin I, an intrinsic membrane protein of synaptic vesicles, has all of the properties of the AP-2 receptor and that AP-2 binds to the second C2 domain in the molecule. Thus, synaptotagmin I may be a multifunctional protein with a function in endocytosis in addition to the previously proposed role in exocytosis.


Subject(s)
Brain/metabolism , Calcium-Binding Proteins , Clathrin/metabolism , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Phosphoproteins/metabolism , Synaptic Vesicles/metabolism , Adaptor Proteins, Vesicular Transport , Adenosine Triphosphate/metabolism , Base Sequence , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cell Polarity , Cytosol/metabolism , Endocytosis , Exocytosis , Membrane Glycoproteins/genetics , Models, Biological , Molecular Sequence Data , Nerve Tissue Proteins/genetics , Protein Binding , Recombinant Fusion Proteins/metabolism , Structure-Activity Relationship , Synaptotagmin I , Synaptotagmins
18.
J Biol Chem ; 268(35): 26386-90, 1993 Dec 15.
Article in English | MEDLINE | ID: mdl-8253763

ABSTRACT

Synaptotagmin I is a Ca(2+)- and phospholipid-binding protein of synaptic vesicles with an essential function in neurotransmission. Ca2+/phospholipid binding by synaptotagmin I may be mediated by its C2 domains, sequence motifs that have been implicated in the Ca2+ regulation of a variety of proteins. However, it is currently unknown if C2 domains are sufficient for Ca2+/phospholipid binding or if they even directly participate in Ca2+/phospholipid binding. In order to address this question, we have studied the Ca2+/phospholipid-binding properties of the first C2 domain of synaptotagmin I. Our results show that this C2 domain by itself binds Ca2+ and phospholipids with high affinity (half-maximal binding at 4-6 microM free Ca2+) and exhibits strong positive cooperativity. The C2 domain is specific for negatively charged phospholipids and for those divalent cations that are known to stimulate synaptic vesicle exocytosis (Ca2+ > Sr2+, Ba2+ >>> Mg2+). These studies establish that C2 domains can serve as independently folding Ca2+/phospholipid-binding domains. Furthermore, the cation specificity and the cooperativity of Ca2+ binding by the C2 domain from synaptotagmin I support a role for this protein in mediating the Ca2+ signal in neurotransmitter release.


Subject(s)
Calcium-Binding Proteins , Calcium/metabolism , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Phospholipids/metabolism , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Carbon/metabolism , DNA Primers , Enzyme Activation , Membrane Glycoproteins/chemistry , Molecular Sequence Data , Nerve Tissue Proteins/chemistry , Protein Kinase C/metabolism , Rats , Synaptotagmin I , Synaptotagmins
19.
J Biol Chem ; 268(9): 6816-22, 1993 Mar 25.
Article in English | MEDLINE | ID: mdl-8454654

ABSTRACT

Synaptotagmin I is an abundant synaptic vesicle protein that binds Ca2+ in a phospholipid-dependent manner and is thought to function in synaptic vesicle exocytosis. We have now studied the phosphorylation of synaptotagmin I. Synaptotagmin I is one of the major substrates in brain for casein kinase II, which phosphorylates synaptotagmin at a single threonine. The phosphorylation site was mapped using recombinant proteins to threonine 128 of synaptotagmin I, which is located in the sequence between the transmembrane region and the C2 domain repeats of synaptotagmin I. The phosphorylation site of synaptotagmin I is also present in synaptotagmin II and is evolutionarily conserved between different species. Preceding the phosphorylation site, synaptotagmins I and II contain a lysine-rich sequence. Casein kinase II phosphorylation of many substrates is strongly stimulated by the addition of polylysine, but phosphorylation of synaptotagmin I by casein kinase II is not. In recombinant proteins, removal of the lysine-rich sequence of synaptotagmin I makes its phosphorylation dependent on exogenous polylysine, suggesting that the lysine-rich sequence in synaptotagmin serves as an endogenous polylysine stimulation signal for casein kinase II. Our data demonstrate that synaptotagmin I is an efficient substrate for casein kinase II at a conserved site with a possible modulatory role in nerve terminal function.


Subject(s)
Calcium-Binding Proteins , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Brain/enzymology , Casein Kinase II , Cattle , Cloning, Molecular , DNA , Escherichia coli , Immunoblotting , Molecular Sequence Data , Phosphorylation , Rats , Recombinant Proteins/metabolism , Substrate Specificity , Synaptotagmin I , Synaptotagmins
20.
Neuron ; 10(2): 307-15, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8439414

ABSTRACT

Synaptotagmin, a major intrinsic membrane protein of synaptic vesicles that binds Ca2+, was purified from bovine brain and immobilized onto Sepharose 4B. Affinity chromatography of brain membrane proteins on immobilized synaptotagmin revealed binding of alpha- and beta-neurexins to synaptotagmin in a Ca(2+)-independent manner. Using a series of recombinant proteins in which glutathione S-transferase was fused to the cytoplasmic domains of three different neurexins or of control proteins, it was found that synaptotagmin specifically interacts with the cytoplasmic domains of neurexins but not of control proteins. This interaction is dependent on a highly conserved, 40 amino acid sequence that makes up most of the cytoplasmic tails of the neurexins. Our data suggest a direct interaction between the cytoplasmic domains of a plasma membrane protein (the neurexins) and a protein specific for a subcellular organelle (synaptotagmin). Such an interaction could have an important role in the docking and targeting of synaptic vesicles in the nerve terminal.


Subject(s)
Brain Chemistry , Calcium-Binding Proteins , Cytoplasm/metabolism , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Receptors, Peptide , Amino Acid Sequence , Animals , Binding Sites , Cattle , Cell Membrane/chemistry , Chromatography, Affinity , Glutathione Transferase/genetics , Immunoblotting , Immunosorbent Techniques , Membrane Glycoproteins/isolation & purification , Membrane Proteins/isolation & purification , Membrane Proteins/metabolism , Molecular Sequence Data , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/isolation & purification , Receptors, Cholinergic/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Synaptic Vesicles/chemistry , Synaptotagmins
SELECTION OF CITATIONS
SEARCH DETAIL
...